TaiGen Biopharmaceuticals Holdings Limited (TPEX:4157)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
11.35
+0.05 (0.44%)
Mar 24, 2026, 1:30 PM CST

TPEX:4157 Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
259.47150.65123.1336.231,295
Revenue Growth (YoY)
72.23%22.35%239.87%-97.20%5426.95%
Cost of Revenue
18.1716.1311.453.7412.72
Gross Profit
241.3134.52111.6932.491,282
Selling, General & Admin
75.0290.5598.972.6499.06
Research & Development
96.88166.07187.48237.52283.28
Operating Expenses
171.91256.62286.39310.16382.34
Operating Income
69.4-122.1-174.7-277.67899.46
Interest Expense
-1.67-1.42-1.14-0.85-0.24
Interest & Investment Income
18.4724.420.388.724.23
Earnings From Equity Investments
-----23.24
Currency Exchange Gain (Loss)
-54.17-15.6851.79-4.24
Other Non Operating Income (Expenses)
-28.760.48149.40.010.04
EBT Excluding Unusual Items
57.44-44.47-21.73-218876
Gain (Loss) on Sale of Investments
-13.55165.220.30.08
Gain (Loss) on Sale of Assets
-----0.08
Asset Writedown
--1.96--12.06-
Pretax Income
57.44-32.89143.49-229.77875.99
Income Tax Expense
12.265.76.767.4100.37
Net Income
45.18-38.58136.73-237.16775.62
Net Income to Common
45.18-38.58136.73-237.16775.62
Shares Outstanding (Basic)
753717717717717
Shares Outstanding (Diluted)
753717717717717
Shares Change (YoY)
4.95%0.03%0.06%-0.07%0.07%
EPS (Basic)
0.06-0.050.19-0.331.08
EPS (Diluted)
0.06-0.050.19-0.331.08
Free Cash Flow
19.48-173.623.57-24.66618.83
Free Cash Flow Per Share
0.03-0.240.01-0.030.86
Gross Margin
93.00%89.29%90.70%89.69%99.02%
Operating Margin
26.74%-81.05%-141.88%-766.41%69.48%
Profit Margin
17.41%-25.61%111.04%-654.61%59.91%
Free Cash Flow Margin
7.51%-115.25%2.90%-68.06%47.80%
EBITDA
86.87-113.76-164.59-267.53909.9
EBITDA Margin
33.48%-75.51%-133.67%-70.29%
D&A For EBITDA
17.478.3410.1110.1410.44
EBIT
69.4-122.1-174.7-277.67899.46
EBIT Margin
26.74%-81.05%-141.88%-69.48%
Effective Tax Rate
21.35%-4.71%-11.46%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.